NASDAQ: TGTX
Tg Therapeutics Inc Stock Ownership - Who owns Tg Therapeutics?

Insider buying vs selling

Have Tg Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Laurence N. CharneyDirector2026-09-105,000$54.96
$274.80kSell
Yann EchelardDirector2025-11-245,000$32.57
$162.85kSell

1 of 1

TGTX insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when TGTX insiders and whales buy or sell their stock.

TGTX Shareholders

What type of owners hold Tg Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Michael S. Weiss22.06%33,760,975$1.94BInsider
Ra Capital Management LP8.25%12,629,868$725.33MInsider
Lindsay A. Md Rosenwald6.18%9,462,616$543.44MInsider
Biotechnologies Sasu Lfb4.97%7,614,855$437.32MInsider
Joan Pons Gimbert2.59%3,959,149$227.37MInsider
Michael Weiser1.50%2,292,241$131.64MInsider
Sean A. Power0.52%798,111$45.84MInsider
Timothy McInerney0.44%674,007$38.71MInsider
David M. Tanen0.39%602,517$34.60MInsider
Joshua A. Kazam0.32%492,852$28.30MInsider

1 of 3

TGTX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
TGTX0.07%48.64%Net SellingNet Selling
IBRX0.02%7.21%Net BuyingNet Selling
CYTK0.12%10.96%Net SellingNet Selling
CAI0.05%81.85%Net BuyingNet Buying
PTGX0.12%22.54%Net SellingNet Buying

Tg Therapeutics Stock Ownership FAQ

Who owns Tg Therapeutics?

Tg Therapeutics (NASDAQ: TGTX) is owned by 0.07% institutional shareholders, 48.64% Tg Therapeutics insiders, and 51.28% retail investors. Michael S. Weiss is the largest individual Tg Therapeutics shareholder, owning 33.76M shares representing 22.06% of the company. Michael S. Weiss's Tg Therapeutics shares are currently valued at $1.94B.

If you're new to stock investing, here's how to buy Tg Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.